Roche, a Swiss global health-care company, has recently received a positive review from the Food and Drug Administration (FDA) concerning their new pre-surgical breast cancer treatment drug, Perjeta. In actuality, a positive review is an understatement. FDA scientists are recommending accelerating the approval process for the drug, a measure usually reserved for pioneering drugs that […]

Learn More